Context
To bring about major changes within organisations, it is also essential to appreciate the importance of the wider culture and context to understand some of the forces that may hinder or hasten the change. The move towards clinical and cost effectiveness is taking place around the world against a background of major restructuring of health services, a move towards explicit rationing, the introduction of increasingly specialised new technology, a fall in the status of the professional, and the presence of high unemployment. This innovative personality (and quite often with extra resources and education to extend their work towards the ideal) and the rest. This will lead in turn to an inevitable increase in the variation of healthcare behaviour and of the outcomes that result, something which is completely contrary to the ideas of clinical effectiveness. I would argue therefore that it is equally, if not more, important to try to understand and change those who find it difficult to shift rather than continuing to target those who change with ease.
The second reason for this broader focus is that in an arena of constant organisational change we are likely to see those who take up new things with alacrity as somehow superior to those who are less enthusiastic about change. However, most organisational experience informs us that diversity in these aspects of personality is often a benefit, with those who hold back acting as a safety anchor against decisions which are too fast or not well enough thought through.4 For these reasons this paper is directed as much towards affecting those slow to change as the rest. Its purpose is to break down the complexity of change into manageable chunks and so to provide a framework for the culture of dissemination and the use of good evidence. The table shows Nevertheless it is an essential first step to make the product itself-the information that needs to be communicated-one which will attract rather than be ignored or even repel. To Marketing strategies In marketing terms, the means of bringing about a change in behaviour involves enhancing the design of the product, its promotion to the right people, and making its price as attractive as possible. '7 In bringing about an evidence-based approach to health care, the products (and to some extent their promotion) include such initiatives as a patient information leaflet, a page on the Internet, a CD-ROM from the Cochrane Library, an audit report, national guidelines, a workshop to learn critical appraisal skills, a "quick sheet" accident and emergency guide, '8 Promoting the evidence Promotion of dissemination in all the appropriate ways and places is an essential step without which even prominent national guidelines will be unnoticed.20 For example, a successful change in practice to reduce x ray films for ankle traumas involved various levels of instruction including a brief lecture, a handout, a pocket card, and two posters in the accident and emergency departments.' There is a continuing task for educational initiatives at both undergraduate and postgraduate levels to provide information about the approach, and training in the core skills involved. In fact, this is transforming medical education in some places. 22 The effects of continuing medical education in changing actual practice seem less promising: a 1992 review of randomised controlled trials found no effects on healthcare outcomes of simply disseminating the evidence by this means.2" Nevertheless, more recent reviews and studies have shown varying benefits for continuing medical education-for example, a study to increase the use of prophylaxis for venous thromboembolism found a significantly greater shift in hospitals where physicians took part in a formal continuing medical education programme than in those who did not, although both groups improved,24 and adding a quality assurance element made no extra difference. A more recent review25 found that methods such as conferences had little impact, but 79% of those which used three or more educational strategies were effective in bringing about change, and in two studies this was followed by an improvement in patient outcomes.
Lessons from health promotion suggest that it is important who backs the products and the initiative as a whole, so the support of professional associations and the promotion by a local opinion leader is likely to be beneficial' although this is not always the case. A recent survey showed that we are a long way from finding the right routes for information to reach the appropriate parts of the organisation." Dawson points out that, in the literature on technology transfer, there are always gatekeepers to information,8 and it will be equally important to identify who these are and to work with them on the most useful ways that they can help in the dissemination process.
In promoting any aspect of the approach, it is necessary to consider the particular motivations and stages of change of the group you are targeting within any promotional literature, and to emphasise points that will be salient to them. If these are not apparent, then the use of focus groups to discover particular concerns and needs should make the product and its promotion more successful.27 It is noticeable, for example, that new treatments (such as counselling in primary care28 or various costly medications) seem to be taken up swiftly often without adequate evidence of effectiveness, whereas others which involve stopping treatments or using simpler ones like aspirin seem more difficult to change.29 The psychology and values which underlie a need to do, rather than not to do, need to be considered during undergraduate training as well as in the promotion of particular products.
Forces that help and hinder All change involves moving away from a state of equilibrium which is maintained by forces which drive forward and counter forces which restrain.'0 Both directly and indirectly, these forces contribute towards the price of change: the costs to the individual person or the group, less the benefits that result. We change by altering the balance between the barriers and the drivers, either by increasing the drivers or reducing the forces which hold us back. Therefore, recognising and dealing with the organisational and individual barriers to change are essential. The figure sets out some of those forces which are likely to operate in introducing an evaluative culture. There will inevitably be others apparent within individual organisations, and it needs local work to discover their importance. rewarded, and how and why it matters, and so on. The more involvement there is in the process, the less chance there will be of clinicians and patients thinking that actions are imposed on them rather than arising through any genuine two way dialogue.8 37 
Resistance
Resistance to change is almost always seen as a bad thing, irrational, and something to be overcome. But this presupposes that all change is good and should be accomplished by the fastest, least challenged means possible. Resistance is actually a necessary process and likely to be beneficial in the early days, a counterforce to unnecessary actions or to changes happening too fast or with insufficient thought. As I described earlier, there are some of us who enjoy change for change's sake, and some who dislike change and value the here-and-now. Because of our present culture, it is those who enjoy change who are likely to rise to the top of organizational structures, and this can make it hard for them to understand the apparent reluctance of others to take on board their enthusiasms. An appreciation of differences will help to create change that is better for its pace being slowed and its consequences better anticipated.4
There are, however, other aspects to resistance which are likely to be barriers to the emergence of an evidence-based culture. For example, anger at the imposition of what may be seen as still more demands may make even the most enthusiastic clinicians dig in their heels. Also, there is a real but unacknowledged implication that the introduction of clinically effective care means that clinicians may, up until then, have being delivering less than effective care. Linked to this is the fear of evaluation and criticism which many of us experience and which is a particular feature of those in the medical profession": no matter how much the approach is emphasised as nonjudgmental, the necessity of monitoring process and outcomes will arouse any underlying dislike of putting one's work up for scrutiny.
The desire to provide rather than withhold treatments, discussed earlier, may also create resistance to particular changes.
These emotional responses and others, both conscious and unconscious, which make up resistance to change, cannot always be overcome. However, as every psychotherapist knows, they need to be acknowledged and this in itself will often take away some or all of their force.
FORCES FOR CHANGE

Rewards
The price of a product or an action is inevitably going to be an extremely important influence on its uptake. The price is the cost payments out or effort involved, less the rewards and benefits received. We know that evidencebased care will always initially require extra time; anything that can be done to reduce this will decrease the cost-for example, having information in appropriate and accessible places in user friendly designs, providing dedicated time for audit for all professional groups, making the whole experience unthreatening, and so on.
The other way to reduce the price of change is to increase the rewards received by change. Learning also takes place through the withdrawal of rewards or even through punishments-such as the increase of insurance costs, the threat of litigation, or the loss of a service. However, an increase in court actions is not necessarily going to lead to more evidence-based health care and may even result in defensive practices.44
Finally, we need to ensure that we are not rewarding clinicians more in any way for not following a clinically effective guideline than we are for following it-for example, by rewarding increased quality less than we do greater activity in an intervention the benefits of which are doubtful.
Education Education in traditional ways may not always show substantial benefits" but several dissemination and education strategies linked to other forces for change are more likely to be successful.'5 It may be that a piecemeal approach to education is not so useful in this regard, and we are better to change our undergraduate and postgraduate education more radically towards a problem solving approach that systematically incorporates the use of evidence." Feedback Feedback of monitoring data-for example, audit data-has had mixed results in bringing about change. Whereas Lomas et al' found it less useful than the use of an opinion leader, others have reported large changes after the feedback of the audit cycle.45 It may be, however, that change through feedback occurs in the longer term only when the change is rewarding in some way to the individual. We know from psychological research that feedback is an important part of behavioural change, acquisition of new skill, and initiating and continuing desired behaviours,46 but it is likely that no one is going to maintain that new behaviour if it does not also have a reward intrinsic to it-for example, interest, career enhancement, belonging to a group, etc.
Opinion leaders, product champions, etc Getting the right person to promote the product is an essential part of marketing and of health promotion and this will usually be someone who is respected or in authority.47
Equally important is to link them into the management system to ensure that their influence is in line with strategy and to make sure they are replaced should they leave. 5 Perhaps because of the strength of the forces of resistance, there is always a tendency to revert to the original position even after good initial change4' and maintenance strategies will be necessary to ensure that this does not happen.
Pressure from inside the organisation The idea that clinically effective care is the responsibility of only clinicians is unlikely to be acceptable or useful. Having in place a total quality system which uses evidence-both clinical and occupational-wherever possible in its decision making will be an important force for change. Within that organisation, teams can themselves be highly influential in encouraging clinically effective care because of the social rewards they provide to those who are committed members.5 This presupposes, however, that the leadership is respected and committed to an evidence-based approach as there is strong evidence that the group is not always as rational as the individual or as well behaved.4" Similarly, teams may not always listen well once they have embarked on a project.8
For this reason it is important that they should be linked into the management structure and should be clear about their role in producing a clinically effective organisation.
Pressures from outside the organisation Nowadays forces for quality may come from numerous agencies outside the organisation: from commissioners, insurers, from professional associations, policy makers, and patients. There is as yet little evidence in the United Kingdom that policy is consistently evidence-based, nor that contracting is being used successfully as a tool for quality,48
although there are purchasers who are using other influences to bring about change through working together with local clinicians.49 Also, the slowly increasing voice of the patient, including the use of complaints and legal actions, may well become an important force for change in the future, although its effects may not be as obviously beneficial as is hoped: patients may make demands on the clinicians which actually curtail them from taking an evidence-based decision.50
Conclusions
There are several areas of research which focus on the factors that influence changes in behaviour and these should prove important in encouraging the development of an evaluative culture. The task is as complex as any other that involves human behaviour, and so the use of relevant strategies with targeted groups is likely to have the best chance of success. Whichever group is the focus for change, whether clinicians, or patients, or managers, the process will best be achieved through a genuine two way flow of information. This will be a very long term endeavour, constantly in need of further consultation and further adaptation to enable it to become a demand from the customers rather than simply a supply of information from above. Finally, the more the change strategies themselves are subjected to rigorous evaluation, the more the task of using good evidence can be spread across an organisation and across policy making itself.
